Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
about
Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies.Tau and neurodegenerative disease: the story so far.Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models.Health benefits of methylxanthines in neurodegenerative diseases.Monoaminergic neuropathology in Alzheimer's disease.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.The neuroprotective effects of caffeine in neurodegenerative diseases.Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study.Tau Proteins and Tauopathies in Alzheimer's Disease.Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'.Caffeine prevents high-intensity exercise-induced increase in enzymatic antioxidant and Na+-K+-ATPase activities and reduction of anxiolytic like-behaviour in rats.Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview.
P2860
Q37307494-47AF7D2C-4365-40C9-945C-136D31F805D3Q38658752-8F7575C2-0550-425B-8C19-ED615D6C8518Q38725557-4D853BFE-34BF-496E-8584-52C42FE72756Q38737146-5A59ADED-9BB1-45A8-A0B4-4503AE6BB5D3Q38772021-2324C96D-A992-4972-8FF7-055565A25EA1Q38809649-C9D76586-EAD9-4208-815B-DCFF8EEC6B00Q39157059-CEB0607B-04FB-43AE-94A8-B489FE47A702Q39186884-ED66665B-A0DC-49EB-BE2D-DFE8DA00A5C1Q40563346-DE5DA013-F5ED-48EB-82A3-06053E0DFE45Q47233523-29E85B1F-80CC-4D74-B126-E8FCEFFAA7E5Q47252033-F47A3E3A-CFAE-444D-8611-8BA4CF3122BEQ47279111-0A3705CC-080C-43AA-82E3-C32873EEB5DFQ47420946-6BCFDA4E-C29A-4986-965F-59FEE434761CQ48176042-AD99F26C-DE2C-4E5C-9E25-B6515A37ED72Q54572410-F88AC572-2FF4-4557-AAB1-A13FD6562D21
P2860
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease
@nl
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
@ast
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
@en
type
label
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease
@nl
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
@ast
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
@en
prefLabel
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease
@nl
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
@ast
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
@en
P2093
P2860
P3181
P1476
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
@en
P2093
Gustavo Basurto-Islas
Jeffry B Stock
Jose R Fernandez
Julie Blanchard
Khalid Iqbal
Maxwell Stock
Michael Voronkov
Sherry Zhang
Yunn Chyn Tung
P2860
P304
P3181
P356
10.1016/J.NEUROBIOLAGING.2014.06.012
P407
P577
2014-06-17T00:00:00Z